Timber Pharmaceuticals Announces 1-For-50 Reverse Stock Split
Timber Pharmaceuticals, Inc. (NYSE:TMBR) ("Timber" or the "Company"), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare